FDA OKs hypertension drug Bystolic

12/18/2007 | Reuters · Bloomberg

The FDA on Monday granted marketing approval for Bystolic, a blood pressure drug developed by Mylan and Forest Laboratories. Forest Labs will be responsible for marketing the drug, also known as nebivolol, while Mylan will receive a share of the royalties and an option to join future co-promotions.

View Full Article in:

Reuters · Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC